Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two new patents for Implemed's technology:

This article was originally published in Clinica

Executive Summary

Implemed has received two additional US patents relating to its antimicrobial polymer technology. Used to develop anti-infective medical devices, the technology, known as Oligon, is based on a process called oligodynamic iontopheresis whereby silver ions are released to destroy microbes on the surface of a device. Implemed's first product using the technology, the Olimpicc peripherally inserted central venous catheter, is sold in Europe. The Watertown, Massachusetts-based company plans to develop partnerships and licensing opportunities to use its technology in a broader spectrum of medical devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083321

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel